Rexulti-1mg (Brexpiprazole Tablet) 1mg

Brexpiprazole works by acting as a partial agonist at dopamine D2 and serotonin 5-HT1A receptors, and as an antagonist at serotonin 5-HT2A receptors. This modulation of serotonergic and dopaminergic neurotransmission helps to restore the balance of certain natural substances in the brain, which can improve symptoms of schizophrenia, depression, and agitation associated with dementia.

The usual starting dose of Rexulti-1mg is 0.5mg or 1mg once daily. Dosage increases usually occur at weekly intervals until you reach a target dose of 2mg once daily. The maximum recommended daily dose is 3mg. Your doctor may prescribe more or less Rexulti depending on how well you tolerate or respond to it.

It is unknown what effect Rexulti-1mg has on a developing fetus, so it should only be used during pregnancy if the benefits outweigh the risks. It is also not known whether brexpiprazole passes into breast milk, so caution is advised if you are breastfeeding. Always consult your healthcare provider before using any medication during pregnancy or breastfeeding.

To order Rexulti-1mg from GNH India, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams across international markets and will ask the buyer to confirm trade or institutional credentials. The team will then reply with pricing, availability, shipping, and the import paperwork.

Rexulti-1mg is considered a second-generation version of aripiprazole (Abilify). The effectiveness of Rexulti and Abilify are similar, but Rexulti has slightly different activity at serotonin and dopamine receptors which may reduce some extrapyramidal side effects such as restlessness. It is also not a controlled substance, which may make it more accessible for some patients.

Rexulti-1mg should be stored at room temperature away from light and moisture. It is important to keep all medications away from children and pets. Always follow the storage instructions provided by your pharmacist or on the medication label to ensure the effectiveness and safety of the medication.

Rexulti-1mg is taken orally, usually once daily, with or without food. It is important to take this medication exactly as prescribed by your doctor. Do not increase your dose or take this drug more often than prescribed, as it will not improve your symptoms any faster and may increase your risk of side effects.

The most serious risks to watch for with Rexulti-1mg include Neuroleptic Malignant Syndrome (NMS), which is characterized by high body temperature, muscle rigidity, and mental disturbances, and Tardive Dyskinesia, which involves involuntary movements of the face and body that may be irreversible. It is also important to monitor for suicidal thoughts, especially in young adults and adolescents.

Rexulti-1mg should not be used by individuals who are allergic to brexpiprazole or any of the ingredients in the medication. It should also be used with caution in elderly patients with dementia-related psychosis, as it may increase the risk of stroke or death. Always consult your healthcare provider before starting any new medication to ensure it is safe and appropriate for you.